The pharmaceutical industry is continuously evolving, with increasing demand for high-efficacy Active Pharmaceutical Ingredients (APIs). Dulaglutide, a GLP-1 receptor agonist, stands as example of this trend. To https://peptidences.com/nces-peptide-process